GlassScriptPhysician profile
Michael H Brasfield
NPI 1194734665
$2,252.60
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $615 · 2021: $621 · 2022: $135 · 2023: $14.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $565.21 | 2019-2022 | |
| Novo Nordisk INC | $300.65 | 2019-2020 | |
| Allergan, INC. | $245.59 | 2019-2020 | |
| Abbvie INC. | $232.17 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.78 | 2019-2020 | |
| Pfizer INC. | $120.55 | 2019-2021 | |
| Amgen INC. | $113.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $92.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $86.73 | 2019-2022 | |
| Astellas Pharma US INC | $42.84 | 2019 | |
| Lilly USA, LLC | $39.74 | 2021 | |
| Glaxosmithkline, LLC. | $34.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.15 | 2019-2022 | |
| Intra-Sana Laboratories | $27.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.76 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.54 | 2021 | |
| Abbott Laboratories | $20.04 | 2021 | |
| Scilex Pharmaceuticals INC. | $18.83 | 2021 | |
| Amarin Pharma, INC. | $16.96 | 2021 | |
| Evoke Pharma, INC. | $16.03 | 2020 | |
| Boston Scientific Corporation | $14.22 | 2023 | |
| Daiichi Sankyo INC. | $14.19 | 2019 | |
| Tactile Systems Technology INC | $13.60 | 2022 | |
| Eisai INC. | $13.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brasfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.